Skip to main content

Advertisement

Table 6 Clinical responses

From: Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients

Patient no. Stage Clinical response* Number of vac. CR duration period (year) PFS (days) OS (days) Outcome
8thvac. Final results
1 IIA CR CR 22 4.5 1659 1775 Alive
2 IIB CR CR 85 4.6 1681 1709 Alive
3 IVA PD PD 8   67 154 Dead
4 III PD PD 8   84 123 Dead
5 III CR PD 12   127 765 Dead
6 III CR CR 69 2.9 1072 1234 Alive
7 IIB CR PD 26 2.0 733 1105 Alive
8 IVB PD PD 10   176 231 Dead
9 IVB PD PD 8   59 300 Dead
10 III CR CR 36 1.1 384 660 Alive
11 IVB PD PD 15   155 217 Dead
  1. *Clinical responses of patients were analyzed after the 8th vaccination and the latest diagnosis points. CR: complete response; PD: progressive disease; PFS: Progression-free survival; OS: overall survival.